Nitto Boseki Co., Ltd.
Nitto Boseki Co., Ltd. (3110.T) Financial Performance & Income Statement Overview
Access detailed quarterly and annual financial reports for Nitto Boseki Co., Ltd. (3110.T), covering cash flow, earnings, and balance sheets.
Nitto Boseki Co., Ltd. (3110.T) Income Statement & Financial Overview
View the income breakdown for Nitto Boseki Co., Ltd. 3110.T across both annual and quarterly reports.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $27.52B | $28.47B | $26.94B | $26.11B |
| Cost of Revenue | $16.90B | $17.89B | $17.33B | $16.55B |
| Gross Profit | $10.62B | $10.58B | $9.61B | $9.57B |
| Gross Profit Ratio | $0.39 | $0.37 | $0.36 | $0.37 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $5.98B | $6.12B | $6.17B | $5.66B |
| Operating Expenses | $5.98B | $6.12B | $6.17B | $5.66B |
| Total Costs & Expenses | $22.88B | $24.003B | $23.50B | $22.21B |
| Interest Income | $20.00M | $0.00 | $0.00 | $4.00M |
| Interest Expense | $152.00M | $0.00 | $131.00M | $124.00M |
| Depreciation & Amortization | $2.12B | $1.97B | -$351.00M | $1.79B |
| EBITDA | $6.67B | $7.55B | $5.01B | $6.76B |
| EBITDA Ratio | $0.24 | $0.27 | $0.19 | $0.26 |
| Operating Income | $4.63B | $4.47B | $3.44B | $3.91B |
| Operating Income Ratio | $0.17 | $0.16 | $0.13 | $0.15 |
| Other Income/Expenses (Net) | -$232.00M | $955.00M | -$458.00M | $811.00M |
| Income Before Tax | $4.40B | $5.42B | $2.98B | $4.72B |
| Income Before Tax Ratio | $0.16 | $0.19 | $0.11 | $0.18 |
| Income Tax Expense | $856.00M | $1.36B | $731.00M | $1.40B |
| Net Income | $3.42B | $4.01B | $2.16B | $3.25B |
| Net Income Ratio | $0.12 | $0.14 | $0.08 | $0.12 |
| EPS | $93.83 | $110.14 | $59.36 | $89.29 |
| Diluted EPS | $93.83 | $110.14 | $59.36 | $89.29 |
| Weighted Avg Shares Outstanding | $36.41M | $36.41M | $36.39M | $36.41M |
| Weighted Avg Shares Outstanding (Diluted) | $36.41M | $36.41M | $36.39M | $36.41M |
Over the past four quarters, Nitto Boseki Co., Ltd. demonstrated steady revenue growth, increasing from $26.11B in Q1 2024 to $27.52B in Q4 2024. Operating income reached $4.63B in Q4 2024, maintaining a consistent 17% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $6.67B, reflecting operational efficiency. Net income dropped to $3.42B, with EPS at $93.83. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan